Re: From ‘Lipopolysaccharide as a biomarker’ to implementation-ready endotoxemia phenotyping in diabetes: Clarifications and a minimal translation pipeline
Indian Journal of Physiology and Pharmacology · 11.07.2026 · 1-2
DOI: 10.25259/ijpp_178_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Physiology and Pharmacology, online erschienen am 11.07.2026. Verfasst von Sowmiya Thiyagarajan und 4 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Thiyagarajan, S., Bhaskar, E., Gayathri, V., Mohanalakshmi, P., & Silambanan, S. (2026). Re: From ‘Lipopolysaccharide as a biomarker’ to implementation-ready endotoxemia phenotyping in diabetes: Clarifications and a minimal translation pipeline. Indian Journal of Physiology and Pharmacology, 0, 1-2. https://doi.org/10.25259/ijpp_178_2026
Vancouver
Thiyagarajan S, Bhaskar E, Gayathri V, Mohanalakshmi P, Silambanan S. Re: From ‘Lipopolysaccharide as a biomarker’ to implementation-ready endotoxemia phenotyping in diabetes: Clarifications and a minimal translation pipeline. Indian Journal of Physiology and Pharmacology. 2026;0:1-2. doi:10.25259/ijpp_178_2026
BibTeX
@article{Thiyagarajan2026,
author = {Thiyagarajan, Sowmiya and Bhaskar, Emmanuel and Gayathri, Veeraraghavan and Mohanalakshmi, Parthasarathy and Silambanan, Santhi},
title = {Re: From ‘Lipopolysaccharide as a biomarker’ to implementation-ready endotoxemia phenotyping in diabetes: Clarifications and a minimal translation pipeline},
journal = {Indian Journal of Physiology and Pharmacology},
year = {2026},
volume = {0},
pages = {1--2},
doi = {10.25259/ijpp_178_2026}
}
EUVIMED